These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26505596)

  • 1. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
    Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
    JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
    Cates CJ; Wieland LS; Oleszczuk M; Kew KM
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
    Peters SP; Kunselman SJ; Icitovic N; Moore WC; Pascual R; Ameredes BT; Boushey HA; Calhoun WJ; Castro M; Cherniack RM; Craig T; Denlinger L; Engle LL; DiMango EA; Fahy JV; Israel E; Jarjour N; Kazani SD; Kraft M; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Wasserman SI; Walter MJ; Wechsler ME; Chinchilli VM; Bleecker ER;
    N Engl J Med; 2010 Oct; 363(18):1715-26. PubMed ID: 20979471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to tiotropium versus salmeterol in asthmatic adults.
    Peters SP; Bleecker ER; Kunselman SJ; Icitovic N; Moore WC; Pascual R; Ameredes BT; Boushey HA; Calhoun WJ; Castro M; Cherniack RM; Craig T; Denlinger LC; Engle LL; Dimango EA; Israel E; Kraft M; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Ramsdell J; Sorkness CA; Sutherland ER; Wasserman SI; Walter MJ; Wechsler ME; Chinchilli VM; Szefler SJ;
    J Allergy Clin Immunol; 2013 Nov; 132(5):1068-1074.e1. PubMed ID: 24084072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma.
    Chipps B; Mosnaim G; Mathur SK; Shaikh A; Khoury S; Gopalan G; Palli SR; Lamerato L; Casciano J; Dotiwala Z; Settipane R
    Allergy Asthma Proc; 2020 Jul; 41(4):248-255. PubMed ID: 32414426
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2012 Apr; 4(4):CD008989. PubMed ID: 22513969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium: a new therapeutic option in asthma.
    Novelli F; Costa F; Latorre M; Malagrinò L; Celi A; Vagaggini B; Paggiaro P
    Monaldi Arch Chest Dis; 2013; 79(3-4):109-15. PubMed ID: 24761528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
    Hodder R; Kesten S; Menjoge S; Viel K
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):157-67. PubMed ID: 18044688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
    Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED
    Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.